Navigation Links
Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
Date:6/29/2011

PRINCETON, N.J., June 29, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Joel Posener, MD, has joined the Company as Executive Medical Director, Neuroscience. Dr. Posener will support PharmaNet project teams conducting clinical trials in psychiatry and neurology, and will provide drug development advice to clients in the area of neuroscience.

"We are thrilled Joel has joined PharmaNet," said Steven Leventer, PhD, Vice President and General Manager, Neuroscience. "His distinguished medical and clinical credentials will be a valuable addition to PharmaNet's experienced neuroscience team. Joel's appointment further demonstrates our commitment to help our clients develop innovative neuroscience therapeutics."

Dr. Posener obtained his medical degree from McGill University, completed a residency in psychiatry and fellowship in psychiatric research at Harvard Medical School and Massachusetts Mental Health Center, and is board certified in Psychiatry. Prior to joining PharmaNet, Dr. Posener held roles at Wyeth as Senior Director, Neuroscience Medical Research and Senior Director, Early Development and Clinical Pharmacology. He directed Phase II projects in a variety of psychiatric indications including cognitive impairment in schizophrenia, bipolar disorder and depression. Dr. Posener has also managed early clinical development programs in schizophrenia, depression and Alzheimer's disease.

Before joining the pharmaceutical industry, Dr. Posener served on the faculty of Harvard Medical School and Washington University School of Medicine in St. Louis, where he was also Medical Director of Metropolitan St. Louis Psychiatric Center, an academically affiliated public psychiatric hospital. He has published
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco
2. Amicus Therapeutics Joins Russell 3000® Index
3. Dr. H. Daniel Perez Joins Celtaxsys Board of Directors
4. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
5. Matthias Spaenle, MD, Joins Oppenheimers Investment Banking Group as Managing Director - Healthcare
6. William T. Boehm Joins Neogens Board of Directors
7. Scott Garrett Joins Water Street Healthcare Partners
8. Sigma® Life Science Joins AMDeCs Vendor Partnership Program, Further Enhancing Value to Academic Medical Research Centers
9. Ed Weimer Joins Delta Point, Inc. as Executive Account Director
10. Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstems Board
11. Former Cerner Chief Operating Officer Joins Netsmart Technologies Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... ON , Aug. 22, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... six month periods ended June 30, 2014.  Biorem,s complete 2014 second quarter ... Financial Summary:Three-months ended June 30, , Six-months ended ... , 2014 , 2013 , 2014 ... , 4,433 , 9,195 Gross profit , 56 ...
(Date:8/22/2014)... Ophthalmic drug delivery technologies or ... endeavors as the anatomy, physiology and biochemistry of ... foreign substances. Ocular drug delivery technologies provide several ... minimal use of needles; also it enables high ... specific targeting within the ocular globe. On the ...
(Date:8/22/2014)... 2014 Nerium International, the go-to, ... the spotlight again. Nerium will showcase its signature ... Body Contouring Cream to Hollywood’s elite at the ... the 66th Primetime Emmy® Awards. , Developed from ... clinical trials show that NeriumAD night cream dramatically ...
(Date:8/21/2014)... at the Institute for Molecular Medicine Finland (FIMM), ... developed a novel "man and machine" decision support ... aid was described in PLOS One ... based on computer vision algorithms similar to those ... of only the diagnostically most relevant areas. Tablet ...
Breaking Biology Technology:Biorem Reports 2014 Second Quarter Results 2Biorem Reports 2014 Second Quarter Results 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 2Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 3A novel 'man and machine' decision support system makes malaria diagnostics more effective 2
... N.Y., Jan. 31 Mr. Donald Fresne, ... that the company has recently,obtained from Harvard ... cover certain technologies related to cancer therapy ... developed jointly,by scientists in the Laboratory for ...
... VCs face more competition from private ... equity and hedge ... their investments to the greentech and biotech industries in the,coming year, ... a recent survey by the U.S. audit, tax and advisory,firm KPMG ...
... 31 Schering-Plough,Corporation (NYSE: SGP ) today ... has accepted the Peg-IFN (peginterferon alfa-2b),supplemental Biologics License ... status for the adjuvant treatment of patients with,Stage ... agency,in the fall of 2007., The Priority ...
Cached Biology Technology:Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6
(Date:8/21/2014)... of the water window? It consists of radiations in ... absorbed by the water in biological tissues. New theoretical ... radiations within the water window. These could be the ... image of the biological samples or to be used ... the physical mechanism needed to efficiently generate the harmonic ...
(Date:8/21/2014)... by an international standards process, will be available soon ... invited review published in the OnlineFirst version of ... official journal of the American Society for Parenteral and ... the occurrence of misconnection that can be harmful and ... used to join medical devices, components, and accessories to ...
(Date:8/21/2014)... University have developed a novel and versatile modeling strategy ... creating new materials as well as for studying polyelectrolytes, ... us to model much larger and more complex polyelectrolyte ... Nan Li, lead author of a paper on the ... of Materials Science and Engineering. "This is a big ...
Breaking Biology News(10 mins):Water window imaging opportunity 2New feeding tube connectors will improve patient safety 2Researchers develop models to study polyelectrolytes, including DNA and RNA 2
... In 2007, researchers of the Max Planck Institute ... in exploratory behaviour in great tits. Birds with a ... (DRD4 gene) showed stronger novelty seeking and exploration behaviour ... tested and found in a lab-raised group of birds. ...
... , Some animals, it seems, are going on a ... these are reactions to rapidly rising temperatures due to ... Aviv University,s Department of Zoology, who has been measuring ... areas where climate change is most extreme. , Changes ...
... with anorexia nervosa, paradoxically, have strikingly high levels of fat ... Their findings, based on MRI imaging of the knees of ... same age, appear in the February issue of the ... that an emaciated young woman with almost no subcutaneous fat ...
Cached Biology News:Great tits: birds with character 2Animals cope with climate change at the dinner table 2Anorexics found to have excess fat-- in their bone marrow 2
... ProteinChip arrays have been developed for ... samples. A variety of ProteinChip chemical ... according to their unique biochemical properties. ... allowing side-by-side sample comparison, and the ...
The thermal printer, 120 V, is used to record fluorescence data acquired with the VersaFluor fluorometry systems. The printer includes a cable and power adaptor....
This thermal printer, 120 V, provides a permanent record of the preprogrammed method and run data for the PROTEAN IEF cell. Includes cable and power adaptor....
... iCycler thermal cycler with 384-well reaction module ... applications. It is equipped with an interchangeable, ... features algorithm temperature monitoring and control and ... sample volumes. It includes the iCycler base ...
Biology Products: